Daniel Keesman, co-CEO and chief operating officer, and Martin Hollenhorst, co-CEO and CFO, as well as all three members of the supervisory board of Lion Bioscience - J rgen Dormann, Klaus Pohle, and Richard Roy - have resigned, the company said last week. Thure Etzold, managing director for Lion Bioscience
Ingelise Saunders has become CEO of proteomics company ACE BioSciences, the
Seattle Genetics announced three new appointments and promotions yesterday: Iqbal Grewal has become vice president for preclinical therapeutics, joining the company from Genentech, where he was a senior scientist in the department of immunology. He holds a PhD in immunology from the University of California Los Angeles, an MS in immunobiology from the
Morris Rosenberg has been promoted to senior vice president of development, from vice president of development. He holds a DSc and an MS in chemical engineering and a BA in biology from
Paul Carter has been promoted to vice president for antibody technologies, from senior director for antibody technologies. He received a PhD in molecular biology and a BA in natural sciences from
Aaron Shatkin has been elected to the board of directors of Serologicals, the company said last week. Shatkin is currently the director of the Center for Advanced Biotechnology and Medicine, as well as a professor of molecular genetics and microbiology at the Robert W. Johnson Medical School in
Kevin Farr has been elected to the board of directors of Beckman Coulter, effective Oct. 8, the company said last week. He is the chief financial officer for Mattel. Farr holds an MBA from Northwestern University's J L Kellogg Graduate School of Business and a bachelor's degree from Michigan State University.
Richard Ulevitch has been named to the scientific advisory board of MultiCell, the company said last week. He is currently chairman of the department of immunology at The Scripps Research Institute in La Jolla, Calif. Ulevitch received a PhD in biochemistry from the
Nick Samaras has been appointed to the board of directors of the Australian Genome Research Facility, he announced last week. Samaras is the founding executive director of Australis Biosciences, a consulting company based in
Steven Knapp has joined the Center for Applied Genetic Technologies at the
Andrew Fire, Alan Guttmacher, Robert Nussbaum, and Eric Topol are among the 65 new members of the
Fire is a professor of pathology and genetics at Stanford University School of Medicine; Guttmacher is the deputy director of the National Human Genome Research Institute; Nussbaum is chief of the genetic disease research branch at NHGRI; and Topol is chairman of the department of cardiovascular medicine at the Cleveland Clinic and professor of medicine and genetics at Case Western Reserve University.
Kelly Ormond was elected as president of the National Society of Genetic Counselors at the society's annual conference in